Fidelity Investments
DERM icon

Fidelity Investments’s Journey Medical DERM Stock Holding History

Fidelity Investments’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.3K Buy
2,194
+1,998
+1,019% +$15.5K ﹤0.01% 4760
2025
Q4 		$1.51K Buy
196
+177
+932% +$1.39K ﹤0.01% 5050
2025
Q3 		$135 Buy
+19
New +$138 ﹤0.01% 5182
2025
Q2 		– Sell
-2
Closed -$13 – 5360
2025
Q1 		$13 Buy
+2
New +$10 ﹤0.01% 5239
2024
Q1 		– Sell
-128
Closed -$734 – 5425
2023
Q4 		$734 Buy
+128
New +$570 ﹤0.01% 4786

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments's DERM Position: Q1 2026 in Review

Fidelity Investments increased its Journey Medical (DERM) stake by 1,019% in Q1 2026, buying an estimated $15.5K and bringing the position to 2,194 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4760.

Fidelity Investments first reported a position in DERM in Q4 2023 and has held it in 5 quarters since. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Fidelity Investments held 2,194 shares of Journey Medical worth $10.3K as of Q1 2026.
  • Fidelity Investments bought 1,998 Journey Medical shares in Q1 2026, an estimated $15.5K.
  • Journey Medical made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4760 holding.
  • Fidelity Investments first reported a position in Journey Medical in Q4 2023 and has held it in 5 quarters since.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.